Diabetes in France
Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients, as this analysis of the French diabetes market reveals.
The use of social media listening techniques is becoming more commonplace by pharmaceutical companies looking to better understand the real world use of medicines. Through analysis of terms relating to specific diseases or medicines, open online information can be analysed to understand use of, and sentiment around, individual drugs or organisations.
In this exclusive white paper, pharmaSocial Intelligence outlines how these techniques can reveal insight from both patients and healthcare providers, by demonstrating online commentary picked up relating to diabetes in France during the final quarter of 2013.
Read this white paper to understand:
• Patient and physician social media commentary on diabetes in France
• How different drug companies within diabetes are perceived
• Notable mentions of individual drugs and trials
• What channels showed more prevalent diabetes conversation
Click on the ‘Download the white paper’ button now to obtain your free copy.
For more information on pharmaSocial Intelligence please visit: